Applied Molecular Transport
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AMTI and buy or sell other stocks, ETFs, and their options commission-free!About AMTI
Applied Molecular Transport, Inc. is a clinical-stage biopharmaceutical company, which engages in the design and development of a pipeline of novel oral biologic product candidates for the treatment of autoimmune, inflammatory, and metabolic diseases. The company was founded by Tahir Mahmood on November 21, 2016 and is headquartered in Menlo Park, CA.
CEOShawn Mikael Cross, MBA
CEOShawn Mikael Cross, MBA
Employees—
Employees—
HeadquartersMenlo Park, California
HeadquartersMenlo Park, California
Founded2016
Founded2016
Employees—
Employees—
AMTI Key Statistics
Market cap11.01M
Market cap11.01M
Price-Earnings ratio-0.14
Price-Earnings ratio-0.14
Dividend yield—
Dividend yield—
Average volume30.06K
Average volume30.06K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.84
52 Week high$0.84
52 Week low$0.1343
52 Week low$0.1343
Stock Snapshot
As of today, Applied Molecular Transport(AMTI) shares are valued at $0.26. The company's market cap stands at 11.01M, with a P/E ratio of -0.14.
On 2025-11-05, Applied Molecular Transport(AMTI) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 30.06K.
Over the past 52 weeks, Applied Molecular Transport(AMTI) stock has traded between a high of $0.84 and a low of $0.13.
Over the past 52 weeks, Applied Molecular Transport(AMTI) stock has traded between a high of $0.84 and a low of $0.13.
People also own
Based on the portfolios of people who own AMTI. This list is generated using Robinhood data, and it’s not a recommendation.